{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:29:22Z","timestamp":1775039362228,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1016\/s0168-3659(02)00212-2","type":"journal-article","created":{"date-parts":[[2002,10,8]],"date-time":"2002-10-08T20:17:16Z","timestamp":1034108236000},"page":"273-286","source":"Crossref","is-referenced-by-count":589,"title":["Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity"],"prefix":"10.1016","volume":"83","author":[{"given":"Cristina","family":"Fonseca","sequence":"first","affiliation":[]},{"given":"S\u00e9rgio","family":"Sim\u00f5es","sequence":"additional","affiliation":[]},{"given":"Rog\u00e9rio","family":"Gaspar","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/S0168-3659(02)00212-2_BIB1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/PL00012081","article-title":"Metastatic breast cancer with resistance to both anthracycline and docetaxel successfully treated with weakly paclitaxel","volume":"6","author":"Ishitobi","year":"2001","journal-title":"Int. J. Clin. Oncol."},{"issue":"3 Suppl. 7","key":"10.1016\/S0168-3659(02)00212-2_BIB2","first-page":"11","article-title":"Chemotherapy for advanced ovarian cancer: overview of randomized trials","volume":"27","author":"Thigpen","year":"2000","journal-title":"Semin. Oncol."},{"issue":"4 Suppl. 14","key":"10.1016\/S0168-3659(02)00212-2_BIB3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/sonc.2001.27607","article-title":"Weekly paclitaxel in advanced non-small cell lung cancer","volume":"28","author":"Chang","year":"2001","journal-title":"Semin. Oncol."},{"issue":"5","key":"10.1016\/S0168-3659(02)00212-2_BIB4","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2165\/00003495-199448050-00009","article-title":"Paclitaxel\u2014a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer","volume":"48","author":"Spencer","year":"1994","journal-title":"Drugs"},{"issue":"1\u20132","key":"10.1016\/S0168-3659(02)00212-2_BIB5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(98)00188-4","article-title":"Pharmaceutical aspects of paclitaxel","volume":"172","author":"Panchagnula","year":"1998","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/S0168-3659(02)00212-2_BIB6","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1200\/JCO.1990.8.7.1263","article-title":"Hypersensitivity reactions from Taxol","volume":"8","author":"Weiss","year":"1990","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/S0168-3659(02)00212-2_BIB7","first-page":"1520","article-title":"Stability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers","volume":"48","author":"Waugh","year":"1991","journal-title":"Am. J. Hosp. Pharm."},{"key":"10.1016\/S0168-3659(02)00212-2_BIB8","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1177\/10600280940280S503","article-title":"Pharmacology and toxicology of Cremophor EL diluent","volume":"28","author":"Dorr","year":"1994","journal-title":"Ann. Pharmacother."},{"issue":"4","key":"10.1016\/S0168-3659(02)00212-2_BIB9","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/jnci\/90.4.300","article-title":"Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study","volume":"90","author":"Szebeni","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"issue":"13","key":"10.1016\/S0168-3659(02)00212-2_BIB10","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","article-title":"Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation","volume":"37","author":"Gelderblom","year":"2001","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/S0168-3659(02)00212-2_BIB11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1023\/A:1016483406511","article-title":"A new parenteral emulsion for the administration of Taxol","volume":"4","author":"Tarr","year":"1987","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/S0168-3659(02)00212-2_BIB12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.2042-7158.1997.tb06744.x","article-title":"A submicron lipid emulsion coated with amphipathic polyethylene glycol for parenteral administration of paclitaxel (Taxol)","volume":"49","author":"Ludenberg","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"issue":"6","key":"10.1016\/S0168-3659(02)00212-2_BIB13","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1023\/A:1018994111594","article-title":"Novel taxol formulations: preparation and characterization of Taxol containing liposomes","volume":"11","author":"Sharma","year":"1994","journal-title":"Pharm. Res."},{"issue":"1\u20132","key":"10.1016\/S0168-3659(02)00212-2_BIB14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0168-3659(99)00166-2","article-title":"Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes","volume":"63","author":"Crosasso","year":"2000","journal-title":"J. Control. Relase"},{"issue":"8","key":"10.1016\/S0168-3659(02)00212-2_BIB15","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/jps.1063","article-title":"Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes","volume":"90","author":"Campbel","year":"2001","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/S0168-3659(02)00212-2_BIB16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/02652049009021832","article-title":"In vitro and in vivo antitumoral activity of free and encapsulated Taxol","volume":"7","author":"Bartoli","year":"1990","journal-title":"J. Microencapsul."},{"issue":"7\u20138","key":"10.1016\/S0168-3659(02)00212-2_BIB17","first-page":"281","article-title":"Novel Taxol formulation: polyvinylpyrrolidone nanoparticle-encapsulated Taxol for drug delivery in cancer chemotherapy","volume":"8","author":"Sharma","year":"1996","journal-title":"Oncol. Res."},{"issue":"11","key":"10.1016\/S0168-3659(02)00212-2_BIB18","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1248\/cpb.49.1444","article-title":"In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel","volume":"49","author":"Chen","year":"2001","journal-title":"Chem. Pharm. Bull."},{"issue":"5","key":"10.1016\/S0168-3659(02)00212-2_BIB19","first-page":"633","article-title":"Nanospheres of biodegradable polymers: a system for clinical administration of an anticancer drug paclitaxel (Taxol\u00ae) Ann","volume":"29","author":"Feng","year":"2000","journal-title":"Acad. Med. Singapore"},{"key":"10.1016\/S0168-3659(02)00212-2_BIB20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0168-3659(00)00364-3","article-title":"Effects of emulsifiers on the controlled release of paclitaxel (Taxol\u00ae) from nanospheres of biodegradable polymers","volume":"71","author":"Feng","year":"2001","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/S0168-3659(02)00212-2_BIB21","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1248\/cpb.44.1935","article-title":"Preparation and characterization of poly(lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent, Taxol","volume":"44","author":"Wang","year":"1996","journal-title":"Chem. Pharm. Bull."},{"issue":"12","key":"10.1016\/S0168-3659(02)00212-2_BIB22","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1248\/bpb.19.1596","article-title":"Pharmacokinetic study of taxol-loaded poly(lactic-co-glycolic acid) microspheres containing isopropyl myristate after targeted delivery to the lung in mice","volume":"19","author":"Sato","year":"1996","journal-title":"Biol. Pharm. Bull."},{"issue":"3","key":"10.1016\/S0168-3659(02)00212-2_BIB23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0168-3659(01)00440-0","article-title":"Fabrication, characterization and in vitro release of paclitaxel (Taxol\u00ae) loaded poly(lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid\/cholesterol emulsifiers","volume":"76","author":"Mu","year":"2001","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/S0168-3659(02)00212-2_BIB24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0378-5173(01)00690-1","article-title":"Paclitaxel loaded poly(l-lactic acid) microspheres: properties of microspheres made with low molecular weight polymers","volume":"222","author":"Liggins","year":"2001","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/S0168-3659(02)00212-2_BIB25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/jps.2600690222","article-title":"Tissue distribution of antitumor drugs associated with polyalkylcyanoacrylate nanoparticles","volume":"69","author":"Couvreur","year":"1980","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/S0168-3659(02)00212-2_BIB26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0378-5173(89)90330-X","article-title":"Clinical pharmacokinetics of doxorubicin in hepatoma patients after a single intravenous injection of free or nanoparticle-bound anthracycline","volume":"54","author":"Rolland","year":"1989","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0168-3659(02)00212-2_BIB27","series-title":"Microencapsulation: Methods and Industrial Applications","first-page":"535","article-title":"The use of drug-loaded nanoparticles in cancer chemotherapy","author":"Leroux","year":"1996"},{"issue":"16","key":"10.1016\/S0168-3659(02)00212-2_BIB28","first-page":"4129","article-title":"Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor","volume":"59","author":"Monsky","year":"1999","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/S0168-3659(02)00212-2_BIB29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0959-8049(05)80025-5","article-title":"Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant cells in culture","volume":"30A","author":"Bennis","year":"1994","journal-title":"Eur. J. Cancer"},{"issue":"15","key":"10.1016\/S0168-3659(02)00212-2_BIB30","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","article-title":"Drug therapy: paclitaxel\u2014review article","volume":"332","author":"Rowinsky","year":"1995","journal-title":"New Engl. J. Med."},{"issue":"4","key":"10.1016\/S0168-3659(02)00212-2_BIB31","first-page":"221","article-title":"Nanoparticle characterization: a comprehensive physicochemical approach","volume":"1","author":"Magenheim","year":"1991","journal-title":"STP Pharma Sci."},{"issue":"1","key":"10.1016\/S0168-3659(02)00212-2_BIB32","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0378-5173(89)90281-0","article-title":"Nanocapsule formation by interfacial polymer deposition following solvent displacement","volume":"55","author":"Fessi","year":"1989","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S0168-3659(02)00212-2_BIB33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"28","author":"Anderson","year":"1997","journal-title":"Adv. Drug Del. Rev."},{"issue":"2","key":"10.1016\/S0168-3659(02)00212-2_BIB34","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0005-2736(01)00386-8","article-title":"A growth factor antagonist as a targeting agent for sterically stabilized liposomes in human small cell lung cancer","volume":"1514","author":"Moreira","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"issue":"1\u20132","key":"10.1016\/S0168-3659(02)00212-2_BIB35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid calorimetric assay for cellular growth and survival: application of proliferation and cytotoxicity assay","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"4","key":"10.1016\/S0168-3659(02)00212-2_BIB36","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00001813-199704000-00011","article-title":"Effects of prolonged versus short-term exposure paclitaxel (taxol) on human tumor colony-forming units","volume":"8","author":"Raymond","year":"1997","journal-title":"Anti-Cancer Drugs"},{"issue":"6","key":"10.1016\/S0168-3659(02)00212-2_BIB37","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/bjc.1993.488","article-title":"Cytotoxic studies of paclitaxel (Taxol\u00ae) in human tumor cell lines","volume":"68","author":"Liebmann","year":"1993","journal-title":"Br. J. Cancer"},{"issue":"8884","key":"10.1016\/S0168-3659(02)00212-2_BIB38","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/0140-6736(93)92789-V","article-title":"Cremophor EL solvent for paclitaxel and toxicity","volume":"342","author":"Liebmann","year":"1993","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/S0168-3659(02)00212-2_BIB39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF00685909","article-title":"The influence of Cremophor EL on the cell cycle effects of paclitaxel (Taxol) in human tumor cell lines","volume":"33","author":"Liebmann","year":"1994","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"2","key":"10.1016\/S0168-3659(02)00212-2_BIB40","first-page":"109","article-title":"Methodology for the preparation of ultra-dispersed polymer systems","volume":"1","author":"Vauthier-Holtzsherer","year":"1991","journal-title":"STP Pharma Sci."},{"key":"10.1016\/S0168-3659(02)00212-2_BIB41","first-page":"163","article-title":"Biodegradable nanoparticles of poly(lactic acid) and poly(lactic acid-co-glycolic acid) for parenteral administration","volume":"Vol. 3","author":"All\u00e9man","year":"1998"},{"key":"10.1016\/S0168-3659(02)00212-2_BIB42","doi-asserted-by":"crossref","first-page":"11650","DOI":"10.1021\/ja00077a095","article-title":"\u2018Hydrophobic collapse\u2019 of Taxol and Taxotere solution conformations in mixtures of water and organic solvent","volume":"115","author":"Velde","year":"1993","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"10.1016\/S0168-3659(02)00212-2_BIB43","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/jps.2600831021","article-title":"Solvent- and Concentration-dependent molecular interactions of Taxol (Paclitaxel)","volume":"83","author":"Balasubramanian","year":"1994","journal-title":"J. Pharm. Sci."},{"issue":"12","key":"10.1016\/S0168-3659(02)00212-2_BIB44","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3109\/03639049809108571","article-title":"Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers","volume":"24","author":"Quintanar-Guerrero","year":"1998","journal-title":"Drug. Dev. Ind. Pharm."},{"issue":"2\u20133","key":"10.1016\/S0168-3659(02)00212-2_BIB45","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0378-5173(93)90369-Q","article-title":"Development of biodegradable microspheres and nanospheres for the controlled release of cyclosporin A","volume":"99","author":"S\u00e1nchez","year":"1993","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/S0168-3659(02)00212-2_BIB46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0378-5173(96)04618-2","article-title":"Optimized preparation of poly(d,l lactic-co-glycolic) acid microspheres and nanospheres for oral administration","volume":"141","author":"Chac\u00f3n","year":"1996","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/S0168-3659(02)00212-2_BIB47","first-page":"11","article-title":"Cell cultures for the assessment of toxicity and uptake of polymeric particulate drug carriers","volume":"3","author":"Maa\u03b2en","year":"1993","journal-title":"STP Pharma Sci."},{"key":"10.1016\/S0168-3659(02)00212-2_BIB48","first-page":"87","article-title":"Polymeric dispersions as drug carriers","volume":"Vol. 3","author":"Bodmeier","year":"1998"},{"issue":"3","key":"10.1016\/S0168-3659(02)00212-2_BIB49","first-page":"197","article-title":"Les polym\u00e8res \u00e0 base d\u2019acides lactiques et glycolique at la d\u00e9livrance contr\u00f4l\u00e9e des principes actifs","volume":"3","author":"Mauduit","year":"1993","journal-title":"STP Pharma Sci."},{"issue":"2","key":"10.1016\/S0168-3659(02)00212-2_BIB50","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1023\/A:1011935222652","article-title":"Influence of surface properties at biodegradable microspheres surfaces: effects on plasma protein adsorption and phagocytosis","volume":"15","author":"Lacasse","year":"1998","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/S0168-3659(02)00212-2_BIB51","first-page":"98","article-title":"Colloidal drug delivery systems for the eye. A comparison of the efficacy of three different polymers: polyisobutylcyanoacrylate, poly(lactic-co-glycolic acid), poly-epsilon-caprolacton","volume":"2","author":"Marshal-Heussler","year":"1992","journal-title":"STP Pharma Sci."},{"issue":"1\u20132","key":"10.1016\/S0168-3659(02)00212-2_BIB52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0168-3659(93)90097-O","article-title":"Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with d,l-lactide\/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior","volume":"25","author":"Niwa","year":"1993","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/S0168-3659(02)00212-2_BIB53","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0168-3659(98)00116-3","article-title":"PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug","volume":"57","author":"Govender","year":"1999","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/S0168-3659(02)00212-2_BIB54","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0168-3659(94)90044-2","article-title":"The preparation of sub-200 nm biodegradable colloidal particles from poly (\u03b2-malic acid-cobenzyl malate) copolymers and their surface modification with poloxamer and poloxamine surfactants","volume":"30","author":"Stolnik","year":"1994","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/S0168-3659(02)00212-2_BIB55","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0378-5173(93)90304-X","article-title":"Surface modification of i.v. injectable biodegradable nanoparticles with poloxamer polymers and poloxamine 908","volume":"89","author":"Muller","year":"1993","journal-title":"Int. J. Pharm."},{"issue":"2\u20133","key":"10.1016\/S0168-3659(02)00212-2_BIB56","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0168-3659(97)00082-5","article-title":"In vitro and in vivo evaluation of taxol release from poly(lactic-co-glycolic acid) microspheres containing isopropyl myristate and degradation of the microspheres","volume":"49","author":"Wang","year":"1997","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/S0168-3659(02)00212-2_BIB57","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00685842","article-title":"Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines","volume":"32","author":"Lopes","year":"1993","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/S0168-3659(02)00212-2_BIB58","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0168-3659(97)00196-X","article-title":"Formulation of l-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release","volume":"52","author":"Gaspar","year":"1998","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/S0168-3659(02)00212-2_BIB59","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/jps.2600750407","article-title":"Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymer","volume":"75","author":"Sanders","year":"1986","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/S0168-3659(02)00212-2_BIB60","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00001813-199112000-00002","article-title":"Taxol: a new and effective anti-cancer drug","volume":"2","author":"Slichenmyer","year":"1991","journal-title":"Anti-Cancer Drugs"},{"issue":"1\u20132","key":"10.1016\/S0168-3659(02)00212-2_BIB61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0378-5173(96)04443-2","article-title":"Solubility and stability of taxol: effects of buffers and cyclodextrins","volume":"133","author":"Dordunoo","year":"1996","journal-title":"Int. J. Pharm."},{"issue":"1\u20133","key":"10.1016\/S0168-3659(02)00212-2_BIB62","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0378-5173(94)90039-6","article-title":"Some parameters influencing cytotoxicity of free doxorubicin and doxorubicin-loaded nanoparticles in sensitive and multidrug resistant leukemic murine cells: incubation time, number of nanoparticles per cell","volume":"102","author":"N\u00e9mati","year":"1994","journal-title":"Int. J. Pharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365902002122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365902002122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T09:50:03Z","timestamp":1554803403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365902002122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S0168365902002122"],"URL":"https:\/\/doi.org\/10.1016\/s0168-3659(02)00212-2","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}